The natural history of pregnancy in patients with systemic lupus erythematosus (SLE) is variable. Fetal wastage is still high in these patients.`-3 This may be due to the exacerbation of the disease with a subsequent change in fetomaternal interaction during the pregnancy. Fetal loss occurs often even in the pregnancies of patients whose disease is well controlled, in whom the abortion may be associated with the presence of anticoagulant or anticardiolipin antibodies. 4 5 The administration of relatively high doses of corticosteroid in combination with aspirin brought about a successful outcome of pregnancy in these patients.' 7 Thus some autoantibodies may have a pathophysiological role in the mechanism of fetal wastage. 8 Patients with habitual abortions, however, may lack anticoagulant activity or anticardiolipin antibodies, and a live birth may occur even in patients showing positive tests for antiphospholipid antibodies. Therefore, it is clinically important to study the factors that influence the prognosis of pregnancies in patients with well controlled SLE. In this paper we suggest that hypocomplementaemia may be an important indicator of a poor prognosis for the fetus in lupus pregnancy.
Patients and methods

PATIENTS
Since 1981 we have seen 38 women, all fulfilling the 1982 American Rheumatism Association revised criteria for the diagnosis of SLE, who wanted children. Their average age was 27 years (range [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] and all were in an inactive stage of the disease"'4 before the studied pregnancy began. The (table  1) . There were no significant differences in erythrocyte sedimentation rate, complete blood counts, liver function, serum creatinine, or antinuclear antibody titre between the groups (data not shown). We have shown in this paper the close association of hypocomplementaemia with a poor prognosis for the fetus. Similar results have been obtained previously for the outcome of lupus pregnancies. '9 20 Low C3 and C4 concentrations were found in four pregnancies, all of which resulted in spontaneous abortion. '9 The report, however, included clinically active patients, who would be expected to have a poor fetomaternal interaction. Furthermore, the authors emphasised the clinical importance of monitoring C3 and C4 activity during pregnancy. Our intention, however, was to assess the relation between the fetal prognosis and laboratory findings before pregnancy of lupus patients in remission. Some of our patients showed low complement activity in their serum samples. As hypocomplementaemia is one of the clinical markers indicating lupus activity it is possible that these patients were not in remission at the studied time.9'3 None of these patients, however, had either apparent clinical manifestations or laboratory findings associated with an exacerbation of the disease. We do not yet know the mechanism by which hypocomplementaemia in pregnancy is produced. Low complementaemia might be attributed to a decreased production of complement factors. This is unlikely, however, because severe dysfunction in the liver or macrophages responsible for complement synthesis did not occur in the patients presented here. We prefer the hypothesis that low serum complement activity might reflect an activation of some immunological factors or an increased formation of immune complexes, which might evoke an immunological disorder, thus impairing the fetomaternal interaction in pregnancy. This is interesting in the light of the antiphospholipid syndrome.2224 This newly proposed entity is characterised by thrombosis and recurrent abortion, and in most cases thrombocytopenia, positive lupus anticoagulant, and a raised anticardiolipin antibody titre were present. Antinuclear antibodies and other serological findings ofautoimmunity are commonly detected in such patients. Some patients may fulfil the American Rheumatism Association criteria for the diagnosis of SLE and constitute a subgroup of SLE, characterised by the symptoms mentioned together with recurrent abortions.
Antiphospholipid antibodies, however, often occurred in patients with a live birth. This may be attributed to the heterogeneity of antiphospholipid antibodies, so that some antiphospholipid antibodies, such as those with complement fixing ability, may cause abortions in these patients, but others not (Sibata, unpublished data).
Taken together, these data indicate that low serum complement activity may be associated with a worse prognosis for the fetus in the pregnancy of patients with SLE who are regarded as inactive according to previously described criteria. Further studies are needed to establish the degree to which such findings are clinically reliable as predictors.
